Regenerative Medicine Market : TOC


Regenerative Medicine Market

Regenerative Medicine Market: Tissue Engineering Technology will Remain Key to Overall Growth: Global Industry Analysis and Opportunity Assessment, 2015-2019

  • REP-GB-1326
  • 2016-08-08
  • 78 Pages
  • Format: pdf ppt
  • Category: Healthcare, Pharmaceuticals and Medical devices

Table Of Content

1. Introduction 

1.1 Report Description 

1.2 Market Segmentation 

1.3 Research Methodology 

1.3.1 Assumptions 

1.4 List of Abbreviations 

2. Executive Summary 

2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2015 & 2019)

2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2015 (US$ Mn) 

2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2015 and 2019 (Value %) 

3. Market Overview 

3.1 Overview 

3.2 Market Drivers 

3.3 Restraints 

3.4 Opportunities 

3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market 

3.5.1 Bargaining power of suppliers 

3.5.2 Bargaining power of buyers 

3.5.3 Threat of new entrants

3.5.4 Threat of substitutes

3.5.5 Competitive rivalry 

3.6 Competitive Landscape 

3.6.1 Market Share Analysis by Key Players, 2012 (Value %) 

3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography 

4. Regenerative Medicine (Bone and Joint) Market, by Technology 

4.1 Introduction 

4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (US$ Mn) 

4.2 Stem Cell Therapy 

4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (US$ Mn) 

4.3 Biomaterials 

4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (US$ Mn) 

4.4 Tissue Engineering

4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (US$ Mn) 

5. Regenerative Medicine (Bone and Joint) Market, by Applications 

5.1 Overview 

5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (US$ Mn) 

5.2 Bone Graft Substitutes 

5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.3 Osteoarticular Diseases 

5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.4 Allogeneic Bones 

5.4.1 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.5 Autogenic Bones 

5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.6 Others 

5.6.1 Global Others Application Market Revenue, 2011 – 2019 (US$ Mn) 

6. Regenerative Medicine (Bone and Joint) Market, by Geography 

6.1 Overview 

6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (US$ Mn) 

6.2 North America 

6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

6.3 Europe 

6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

6.4 Asia-Pacific 

6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

6.5 Rest of the World (RoW) 

6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

7. Recommendations 

7.1 Market Strategy for Success 

7.1.1 Rigorous research and development initiatives for innovative products 

7.1.2 Investing in emerging economies 

7.2 Barriers and Future Assumptions 

7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth 

8. Company Profiles 

8.1 Anika Therapeutics, Inc. 

8.1.1 Company Overview 

8.1.2 Financial Overview 

8.1.3 Product Portfolio 

8.1.4 Business Strategies 

8.1.4.1 Distribution agreements for business expansion 

8.1.5 Recent Developments 

8.2 Arthrex, Inc. 

8.2.1 Company Overview 

8.2.2 Financial Overview 

8.2.3 Product Portfolio 

8.2.4 Business Strategies 

8.2.4.1 Mergers and acquisitions for business expansion 

8.2.4.2 Distribution agreement for market penetration 

8.2.5 Recent Developments 

8.3 Baxter International, Inc. 

8.3.1 Company Overview 

8.3.2 Financial Overview 

8.3.3 Product Portfolio 

8.3.4 Business Strategies 

8.3.4.1 Acquisition for business expansion 

8.3.4.2 Public-private partnership for market penetration 

8.3.4.3 New product development 

8.3.5 Recent Developments 

8.4 CONMED Corporation 

8.4.1 Company Overview 

8.4.2 Financial Overview 

8.4.3 Product Portfolio 

8.4.4 Business Strategies 

8.4.4.1 Merger and acquisition for business expansion 

8.4.5 Recent Developments 

8.5 DePuy Synthes, Inc. 

8.5.1 Company Overview 

8.5.2 Financial Overview 

8.5.3 Product Portfolio 

8.5.4 Business Strategies 

8.5.4.1 Extensive research and development activities 

8.5.4.2 Relationship with healthcare professionals 

8.5.5 Recent Developments 

8.6 Medtronic, Inc. 

8.6.1 Company Overview 

8.6.2 Financial Overview 

8.6.3 Product Portfolio 

8.6.4 Business Strategies 

8.6.4.1 Strategic partnership and acquisition 

8.6.5 Recent Developments 

8.7 Smith & Nephew plc 

8.7.1 Company Overview 

8.7.2 Financial Overview 

8.7.3 Product Portfolio 

8.7.4 Business Strategies 

8.7.4.1 Mergers and acquisitions for business expansion 

8.7.4.2 Distribution strategies for market penetration 

8.7.5 Recent Developments 

8.8 Stryker Corporation 

8.8.1 Company Overview 

8.8.2 Financial Overview 

8.8.3 Product Portfolio 

8.8.4 Business Strategies 

8.8.4.1 Focus on R&D activities 

8.8.4.2 Acquisitions for market penetration 

8.8.5 Recent Developments 

8.9 Zimmer Holdings, Inc. 

8.9.1 Business Overview 

8.9.2 Financial Overview 

8.9.3 Product Portfolio 

8.9.4 Business Strategies 

8.9.4.1 Mergers and acquisitions for business expansion 

8.9.5 Recent Developments 

List of Tables

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2015 & 2019)

TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (US$ Mn) 

TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (US$ Mn) 

TABLE 5 Comparative Analysis: Various Bone Graft Substitutes

TABLE 6 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (US$ Mn) 

List of Figures

FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation

FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2015 (US$ Mn)

FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2015 & 2019 (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market

FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)

FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2015 Value (%)

FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (US$ Mn)

FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (US$ Mn)